REGN vs TRUE · P/E 14, rev $14.34B vs rev $175.6M
Regeneron Pharmaceuticals Inc (REGN) versus TrueCar Inc (TRUE) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
TrueCar Inc (TRUE) is a internet content & information company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TRUE revenue for 2024-12-31 was $175.6M. Net income was -$31.0M. Revenue was up 10.6% from 2023-12-31 to 2024-12-31. TRUE currently screens at market cap $167.5M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TRUE currently screens at market cap $167.5M.
Not investment advice. Open the REGN and TRUE stock pages for the full models.
Not investment advice.